ES2062940A1 - Gastrokinetic agent, process for its preparation and pharmaceutical compositions containing said agent - Google Patents

Gastrokinetic agent, process for its preparation and pharmaceutical compositions containing said agent

Info

Publication number
ES2062940A1
ES2062940A1 ES09300493A ES9300493A ES2062940A1 ES 2062940 A1 ES2062940 A1 ES 2062940A1 ES 09300493 A ES09300493 A ES 09300493A ES 9300493 A ES9300493 A ES 9300493A ES 2062940 A1 ES2062940 A1 ES 2062940A1
Authority
ES
Spain
Prior art keywords
agent
preparation
pharmaceutical compositions
compositions containing
gastrokinetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09300493A
Other languages
Spanish (es)
Other versions
ES2062940B1 (en
Inventor
Ges Jose Maria Caldero
Vega Antonio Monge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vita Invest SA
Original Assignee
Vita Invest SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Invest SA filed Critical Vita Invest SA
Priority to ES09300493A priority Critical patent/ES2062940B1/en
Priority to PCT/ES1994/000021 priority patent/WO1994020494A1/en
Priority to AU62085/94A priority patent/AU6208594A/en
Priority to ZA941673A priority patent/ZA941673B/en
Publication of ES2062940A1 publication Critical patent/ES2062940A1/en
Application granted granted Critical
Publication of ES2062940B1 publication Critical patent/ES2062940B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

The invention discloses a new piperazinylbenzothiazole derivative, 2-[1-(4-piperonyl)piperazinyl]benzothiazole, having the formula (I) and pharmaceutically acceptable salts thereof, the processes for its preparation, its application as agents for stimulating gastrointestinal motility, and pharmaceutical compositions containing said derivative.
ES09300493A 1993-03-11 1993-03-11 GASTROCINETIC AGENT, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT. Expired - Fee Related ES2062940B1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ES09300493A ES2062940B1 (en) 1993-03-11 1993-03-11 GASTROCINETIC AGENT, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
PCT/ES1994/000021 WO1994020494A1 (en) 1993-03-11 1994-03-03 Gastrokinetic agent, process for its preparation and pharmaceutical compositions containing said agent
AU62085/94A AU6208594A (en) 1993-03-11 1994-03-03 Gastrokinetic agent, process for its preparation and pharmaceutical compositions containing said agent
ZA941673A ZA941673B (en) 1993-03-11 1994-04-10 A gastrokinetic agent its method of preparation and pharmaceutical compositions containing it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09300493A ES2062940B1 (en) 1993-03-11 1993-03-11 GASTROCINETIC AGENT, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.

Publications (2)

Publication Number Publication Date
ES2062940A1 true ES2062940A1 (en) 1994-12-16
ES2062940B1 ES2062940B1 (en) 1995-06-16

Family

ID=8281067

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09300493A Expired - Fee Related ES2062940B1 (en) 1993-03-11 1993-03-11 GASTROCINETIC AGENT, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.

Country Status (4)

Country Link
AU (1) AU6208594A (en)
ES (1) ES2062940B1 (en)
WO (1) WO1994020494A1 (en)
ZA (1) ZA941673B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4832699A (en) * 1998-06-30 2000-01-17 Neurogen Corporation 1-(benzothiazol-2-yl)-4-(1-phenylmethyl)piperazines: dopamine receptor subtype specific ligands
US6291463B1 (en) 1998-06-30 2001-09-18 Neurogen Corporation 1-(Benzothiazol-2-yl)-4-(1-phenylmethyl) piperazines: dopamine receptor subtype specific ligands

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1187680A (en) * 1967-11-15 1970-04-15 Science Union & Cie New Heterocyclic Substituted Piperazines
ES411984A1 (en) * 1972-02-29 1976-06-16 Pierrel Spa Nitrogen containing isoprenoid compounds
ES439870A3 (en) * 1975-07-31 1977-03-16 Rocador Sa Procedure for the obtaining of new amides of piperonil-piperazine. (Machine-translation by Google Translate, not legally binding)
ES453269A1 (en) * 1976-11-12 1977-11-16 Boehringer Mannheim Gmbh PROCEDURE FOR OBTAINING N-3,4-METHYLEDIOXYBENZYL-N '3, 7, 11-TRIMETHYL 2, 6, 10-DODECATRIENYLPIPERAZINE.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1595923A1 (en) * 1965-02-20 1969-11-27 Merck Ag E 1-Aralkyl-4- (thiazolyl-2) -piperazines and processes for their preparation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1187680A (en) * 1967-11-15 1970-04-15 Science Union & Cie New Heterocyclic Substituted Piperazines
ES411984A1 (en) * 1972-02-29 1976-06-16 Pierrel Spa Nitrogen containing isoprenoid compounds
ES439870A3 (en) * 1975-07-31 1977-03-16 Rocador Sa Procedure for the obtaining of new amides of piperonil-piperazine. (Machine-translation by Google Translate, not legally binding)
ES453269A1 (en) * 1976-11-12 1977-11-16 Boehringer Mannheim Gmbh PROCEDURE FOR OBTAINING N-3,4-METHYLEDIOXYBENZYL-N '3, 7, 11-TRIMETHYL 2, 6, 10-DODECATRIENYLPIPERAZINE.

Also Published As

Publication number Publication date
ZA941673B (en) 1994-10-12
ES2062940B1 (en) 1995-06-16
AU6208594A (en) 1994-09-26
WO1994020494A1 (en) 1994-09-15

Similar Documents

Publication Publication Date Title
IL136044A (en) 2-aminoacetamide derivatives and pharmaceutical compositions containing the same
YU68199A (en) Pharmaceutical formulations containing voriconazole
SE9904505D0 (en) Novel compounds
IL127244A (en) Substituted amines, methods of their preparation and pharmaceutical compositions containing them
HUT68963A (en) Novel 4-arylpiperazines and 4-arylpiperidines, pharmaceutical compositions comprising them and the proces for producing thereof
BG104877A (en) N-substituted anminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
CA2277274A1 (en) Crystal form 0 of clarithromycin
NZ237023A (en) 17beta-substituted-4-aza-5alpha-androstan-3-ones and pharmaceutical compositions
BG101250A (en) Salts of an anti-migraine indole derivative
NO996108L (en) 9 oksinerytromycinderivater
NO20015172L (en) 1-methyl-erythromycin derivatives
NO20020282L (en) New diphenyl-piperidine derivative
GB0109122D0 (en) Novel compounds
AP9801321A0 (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-h-indole derivatives.
NO304113B1 (en) Crystalline thiagabine hydrochloride monohydrate, pharmaceutical composition comprising it, and use thereof for the manufacture of a medicament
IL113365A0 (en) 5-heterocyclo-1,5-benzodiazepine derivatives, their preparation and use and pharmaceutical compositions containing them
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
GEP20043227B (en) 5HT1 Antagonists for Antidepressant Therapy
HRP940458B1 (en) New bis-naphtalimides for the treatment of canser
MY114282A (en) Anthracycline derivatives
TW252979B (en)
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
YU31995A (en) Glycopyranoside Benzothiophenes, A Process For Their Obtaining And Their Pharmaceutical Formulation
NO305560B1 (en) Crystalline 3- (4-hexyloxy-1,2,5-thiadiazol-3-yl) -1,2,5,6-tetrahydro-1-methylpyridine - (+) - L-hydrogen tartrate, pharmaceutical preparations comprising the compound and the use of the compound for the manufacture of a medicament
GEP20063759B (en) Novel Benzothiazine and Benzothiadiazine Derivatives, Method for Preparing Same and Pharmaceutical Compositions Containing Same

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19991102